Reaktion #1509576

ord-8856ebaee96b4a24a0e75bfb0b96c6a7

Reaktionsgleichung

Cc1cc(CN2CCC(N3C(=O)CCC3C(=O)O)CC2)ccc1Cl
1-[1-(4-Chloro-3-methyl-benzyl)-piperidin-4-yl]-5-oxo-pyrrolidine-2-carboxylic acid
CCN(C(C)C)C(C)C
DIPEA
CCN(C(C)C)C(C)C
DIPEA
CN(C)C(On1nnc2cccnc21)=[N+](C)C.F[P-](F)(F)(F)(F)F
HATU
Cn1nnnc1-c1cc(N)cc(Br)c1
3-Bromo-5-(1-methyl-1H-tetrazol-5-yl)-phenylamine
Cc1cc(CN2CCC(N3C(=O)CCC3C(=O)Nc3cc(Br)cc(-c4nnnn4C)c3)CC2)ccc1Cl
title compound
Cc1cc(CN2CCC(N3C(=O)CCC3C(=O)Nc3cc(Br)cc(-c4nnnn4C)c3)CC2)ccc1Cl
1-[1-(4-Chloro-3-methyl-benzyl)-piperidin-4-yl]-5-oxo-pyrrolidine-2-carboxylic acid [3-bromo-5-(1-methyl-1H-tetrazol-5-yl)-phenyl]-amide

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    FiltrationThe reaction mixture was filtered
  2. 2
    Sonstigethe filtrate partitioned between water and EtOAc
  3. 3
    SonstigeThe organic layer was separated
  4. 4
    Sonstigedried
  5. 5
    Einengenconcentrated in vacuum
  6. 6
    Sonstigethe residue purified by flash chromatography (DCM:MeOH 100:0 to 95:5 gradient)

Vorschrift

To a solution of 1-[1-(4-Chloro-3-methyl-benzyl)-piperidin-4-yl]-5-oxo-pyrrolidine-2-carboxylic acid as DIPEA salt (2.6 g) in DMF (100 ml) was added DIPEA (2.1 g), and HATU (4 g). 3-Bromo-5-(1-methyl-1H-tetrazol-5-yl)-phenylamine (1.4 g) was added and the reaction stirred overnight at rt. The reaction mixture was filtered and the filtrate partitioned between water and EtOAc. The organic layer was separated, dried and concentrated in vacuum and the residue purified by flash chromatography (DCM:MeOH 100:0 to 95:5 gradient) to give the title compound (400 mg). Rf=0.19 (95:5 DCM:MeOH).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: USRE045323E1uspto-grants-2015_01